# Daniel Devorsetz

> Daniel Devorsetz is a debt financing investor at Horizon Technology Finance backing Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Horizon Technology Finance](https://shizune.co/investors/profile/horizon-technology-finance)
- Location: Farmington, United States
- Total investments: 1
- Last investment: Sep 2024
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/daniel-devorsetz-945a085

Daniel Devorsetz is a debt financing investor at Horizon Technology Finance in Farmington focused on Health Care and Biotechnology. Jerry Michaud is the President and BOD Member of Horizon Technology Finance. Jerry attended Northeastern University, Rutgers University, and the University of Phoenix.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 7 | 700% |
| Biotechnology | 3 | 300% |
| Medical Device | 3 | 300% |
| Medical | 2 | 200% |
| Therapeutics | 2 | 200% |

26 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Debt Financing | 8 | 800% |
| Funding Round | 1 | 100% |
| Post-IPO Debt | 1 | 100% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 9 | 900% |
| Canada | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GT Medical Technologies | GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement. | $35M | Debt Financing | Sep 12, 2024 |  |

1 of 1 investments shown.

## About Horizon Technology Finance

VC Fund · Farmington, United States

Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billionin venture loans to thousands of companies.The company was founded in 2003 and is headquartered in Farmington, Connecticut.

5 contacts available at Horizon Technology Finance.

| Name | Title | Profile |
| --- | --- | --- |
| Apostolos Apostolakis | Chief Credit Officer | https://shizune.co/investors/profile/apostolos-apostolakis |
| Bryce Bewley | Venture Debt | https://shizune.co/investors/profile/bryce-bewley |
| Daniel Devorsetz | Senior Vice President and Chief Investment Officer | https://shizune.co/investors/profile/daniel-s-devorsetz |
| Diane Earle | Chief Credit Officer | https://shizune.co/investors/profile/diane-earle |
| Gary Moro | Vice President | https://shizune.co/investors/profile/gary-moro |

## Similar investors

### Similar stage
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Development Bank of Wales](https://shizune.co/investors/profile/development-bank-of-wales) — VC Fund
- [The FSE Group](https://shizune.co/investors/profile/finance-south-east) — VC Fund

## FAQ

### What does Daniel Devorsetz invest in?

Daniel Devorsetz invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Debt Financing and Funding Round stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Daniel Devorsetz last invest?

The most recent investment recorded for Daniel Devorsetz closed in Sep 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co